3-Hydrazino-6-methyl-5H-[1,2,4]triazino[5,6-b]indole, 95.0%, 1g

2,6-BIS[(2R,4S,5S)-1-BENZYL-4,5-DIPHENYLIMIDAZOLIDIN-2-YL]PYRIDINE, 95%, 50mg

TERT-BUTYL 3,3-DIFLUOROCYCLOPENTYLCARBAMATE, 95.0%, 100mg

GC capillary column ROTI®Cap-5, 30 m, 0.53 mm, 5.00 µm, 1 Piece(s)

2-Bocaminomethyl-indan-2-carboxylic acid, 98.0%, 1g

3-Bromopyridine-4-methanol, 97.0%, 25g

Ethyl 5-oxo-1-tosyl-2,3,4,5-tetrahydro-1H-benzo[b]azepine-4-carboxylate, 95.0%, 1g

2-Amino-3,5-dichlorobenzaldehyde, 98+%, 500mg

4-Amino-2,6-difluorophenol hydrochloride, 95.0%, 1g

2,6-Di-tert-butyl-4-hydroxy-4-methylcyclohexa-2,5-dien-1-one, 98%, 250mg

SulfoxFluor, 100mg

N-benzyl-4-chloro-N-cyclohexylbenzamide, 98%, 250mg

Propanoic acid, 2-[4-[(6-chloro-2-benzoxazolyl)oxy]phenoxy]-, ethyl ester, 100mg